BioSpace News Archive

Drug Development

Clinical Catch-up for June 10-14

Last week there were quite a few clinical trials whose data were presented. Many were at the American Diabetes Association 79th Scientific Sessions, while others were presented at separate meetings or independently. Here’s a look.

June 14, 2019
·
6 min read
·
Mark Terry
Drug Development

Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint

Based on the results, which were not disclosed at this time, the company said it will begin to plan for regulatory approval in China.

June 14, 2019
·
2 min read
·
Alex Keown
Policy

FDA Warns About Risk of Fecal Transplants Following Patient Death

The stool sample used in the experimental procedure was not properly tested, the FDA said.

June 14, 2019
·
2 min read
·
Alex Keown
Drug Development

Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints

Tremfya hit the mark in two late-stage psoriatic arthritis trials, setting the stage for another potential approval.

June 14, 2019
·
2 min read
·
Alex Keown
Biotech Bay

Researchers Believe an Enterovirus is at the Root of Rare, Polio-Like Disease

AFM, a polio-like condition, has infected more than 500 children since 2014. Scientists may have discovered the root of the disease.

June 14, 2019
·
2 min read
·
Alex Keown
Drug Development

Global Blood Therapeutics’ Sickle Cell Disease Drug Hits the Mark in Phase III Trial

The HOPE trial involved 274 patients with SCD from 60 institutions across 12 countries.

June 14, 2019
·
2 min read
·
Mark Terry
Drug Development

Lilly’s Taltz Superior in Head-to-Head with AbbVie’s Humira in Psoriatic Arthritis

The primary endpoint of the study was to show that Taltz was superior to Humira in treating PsA.

June 14, 2019
·
3 min read
·
Mark Terry
Drug Development

Bluebird Bio Presents More Data on its $1.8 Million Gene Therapy Zynteglo

Cambridge, Mass.-based bluebird bio released updated results from three clinical trials of its LentiGlobin gene therapy for transfusion-dependent Beta-thalassemia.

June 14, 2019
·
3 min read
·
Mark Terry
FDA

FDA Action Alert: Merck, Agios and AMAG Pharma

June is turning out to be a busy month for approvals for the U.S. Food and Drug Administration. The agency has a slate of PDUFA dates this week, including two for Merck alone. Here’s a look.

June 14, 2019
·
3 min read
·
Mark Terry
Univar Solutions tops ICIS 2019 chemical distributors ranking in North America with $6.3bn in sales

Univar Solutions tops the 10th ICIS Top 100 Chemical Distributors ranking in North America announced today.

June 14, 2019
·
3 min read